Chief Operating Officer (15) · Insight Molecular Diagnostics Inc. (IMDX)

Albert Parker

A named executive officer of Insight Molecular Diagnostics in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,399,993

Salary $348,948Bonus $133,465

FY2019: $911,353

1st of 5 named executive officers at Insight Molecular Diagnostics by FY2020 total.

5 named officers on file for Insight Molecular Diagnostics, FY2020

Albert Parker’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Insight Molecular Diagnostics’s whole pay program stands against its peers

  • Insight Molecular Diagnostics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 21, 2021 (DEF 14A).

Free

Get Albert Parker’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Albert Parker compensation by year

Insight Molecular Diagnostics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Insight Molecular Diagnostics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$350,233$348,948
Bonus$57,120$133,465
Option awards$490,000$530,363
Non-equity incentive$0$0
Pension and deferred compensation$0$1,082
All other$14,000$386,135
Total$911,353$1,399,993

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Insight Molecular Diagnostics Inc. DEF 14A filed May 21, 2021, accession 0001493152-21-012508, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Insight Molecular Diagnostics Inc. filed document, accession 0001493152-21-012508. Every figure is read from that document and cited to the page and table it appears in. Filed May 21, 2021.

$911K
$1.4M
FY19
FY20
SalaryBonusOption awardsAll other

Insight Molecular Diagnostics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Albert Parker · this pageChief Operating Officer (15)$1,399,993
Mitchell LevineChief Financial Officer (11)$1,058,460
Ronald AndrewsPresident and Chief Executive Officer$1,046,850
Douglas RossChief Science Officer$980,437
Padma SundarSenior Vice President, Marketing and Market Access (12)$908,372

The full Insight Molecular Diagnostics compensation record

free company brief

This page is one person within Insight Molecular Diagnostics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Insight Molecular Diagnostics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Albert Parker's compensation dossier · One-time report. No refunds.